Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Shaun Fleming"'
Autor:
Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Despite an increasing desire to use historical cohorts as “synthetic” controls for new drug evaluation, limited data exist regarding the comparability of real-world outcomes to those in clinical trials. Governmental cancer data often lac
Externí odkaz:
https://doaj.org/article/8934e2c0d348469ca8fbc945fd4e9089
Autor:
Shaun Fleming, John Reynolds, Ashish Bajel, Nicola Venn, John Kwan, John Moore, David Yeung, Nalini Pati, Michael Leahy, Sushma Kollipara, Emma Verner, Leanne Berkahn, Rosemary Sutton, Andrew Wei, Matthew Greenwood
Publikováno v:
HemaSphere, Vol 7, p e811479d (2023)
Externí odkaz:
https://doaj.org/article/66d5b696a33040228d793890b514f92f
Autor:
Anthony Selwyn Stein, Mojca Jongen-Lavrencic, Sylvain Garciaz, Gerwin A Huls, Abhishek Maiti, Nicolas Boissel, Stephane De Botton, Shaun Fleming, C. Michel Zwaan, David C. de Leeuw, Pinkal Desai, Martha Lucia Arellano, David Avigan, Saskia Langemeijer, Kyle Jensen, Timothy Wagenaar, Gu MI, Giovanni Abbadessa, Ashish Bajel
Publikováno v:
HemaSphere, Vol 7, p e66387cd (2023)
Externí odkaz:
https://doaj.org/article/18f46986af184ccba44a04935f01961a
Autor:
Giovanni Marconi, Shukaib Arslan, Shaun Fleming, Antonio Curti, James S Blachly, Giovanni Martinelli, Matteo Giovanni Della Porta, Ashish Bajel, Tim Sauer, Martina Crysandt, Arnaud Pigneux, Marina Konopleva, Yotvat Marmor, Shringi Sharma, Nairouz Elgeioushi, Emily Rowe, Patricia Cheung, Ekaterina Jahn, Jamal Saeh, Raoul Tibes, Fathima Zumla Cader, Nitin Jain
Publikováno v:
HemaSphere, Vol 7, p e80196f1 (2023)
Externí odkaz:
https://doaj.org/article/5275a0432b0c4e3b8794b9932bafe30c
Autor:
Shaun Fleming, Gail Roboz, Amir T. Fathi, Tian Y. Zhang, Andrew Wei, Hetty Carraway, Leanne Holes, Erica Petrlik, Thomas Prebet, Daniel Lopes De Menezes, Iryna Bluemmert, Hao Sun, Farhad Ravandi
Publikováno v:
HemaSphere, Vol 7, p e27202d1 (2023)
Externí odkaz:
https://doaj.org/article/aa21f861f6974c24894808e3e451238e
Publikováno v:
Frontiers in Psychology, Vol 14 (2023)
The animate monitoring hypothesis (AMH) purports that humans evolved specialized mechanisms that prioritize attention to animates over inanimates. Importantly, the hypothesis emphasizes that any animate—an entity that can move on its own—should t
Externí odkaz:
https://doaj.org/article/ff62fb7a71aa4e83869194c6c2e99fae
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Measurable residual disease (MRD) is being recognised as an optimal method for assessing depth of response, identifying higher risk of relapse, and guiding response-based treatment paradigms for multiple myeloma (MM). Although MRD negativity is incre
Externí odkaz:
https://doaj.org/article/1085de1ead3940ab9874a7928818bdd5
Autor:
Lucy C. Fox, Katherine D. Cummins, Ben Costello, David Yeung, Rebecca Cleary, Cecily Forsyth, Maciek Tatarczuch, Kate Burbury, Olga Motorna, Jake Shortt, Shaun Fleming, Andrew McQuillan, Anthony Schwarer, Rosemary Harrup, Amy Holmes, Sumita Ratnasingam, Kah-Lok Chan, Wei-Hsun Hsu, Asma Ashraf, Faye Putt, Andrew Grigg
Publikováno v:
Blood Advances, Vol 1, Iss 13, Pp 802-811 (2017)
Abstract: Dasatinib has shown superiority over imatinib in achieving molecular responses (MRs) in chronic phase chronic myeloid leukemia but with a different toxicity profile, which may impact its overall benefit. Reported toxicities include pleural
Externí odkaz:
https://doaj.org/article/80ddfac2f5cf487793c7b79283709231
Autor:
Sumita Ratnasingam, Patricia A. Walker, Huy Tran, Zane S. Kaplan, James D. McFadyen, Huyen Tran, Tse-Chieh Teh, Shaun Fleming, John V. Catalano, Sanjeev D. Chunilal, Anna Johnston, Stephen S. Opat, Jake Shortt
Publikováno v:
Blood Advances, Vol 1, Iss 1, Pp 31-35 (2016)
Abstract: Certain patients with antibody-mediated autoimmune disease exhibit poor responses to conventional immunosuppression, including B-cell depletion with rituximab. Proteasome inhibitors such as bortezomib demonstrate pleiotropic immunomodulator
Externí odkaz:
https://doaj.org/article/2edb6b9a60f64e6f889870bc4e0fcc54
Autor:
Silvia C. W. Ling, Edwin K. K. Lau, Ammira Al-Shabeeb, Angela Nikolic, Albert Catalano, Harry Iland, Noemi Horvath, P. Joy Ho, Simon Harrison, Shaun Fleming, Douglas E. Joshua, John D. Allen
Publikováno v:
Haematologica, Vol 97, Iss 1 (2012)
Background Multiple myeloma, a malignancy of the antibody-secreting plasma cells, remains incurable by current therapy. However, the proteasome inhibitor bortezomib and other new drugs are revolutionizing its treatment. It remains unclear why myeloma
Externí odkaz:
https://doaj.org/article/72d07a354b5b43998c96334c6988a1bf